News & Analysis as of

Cosmetics

Katten Muchin Rosenman LLP

Understanding FDA Records Access Under MoCRA

The U.S. Food and Drug Administration ("FDA") released a draft guidance document in January 2026 titled "FDA Records Access Authority for Cosmetic Products: Guidance for Industry" (the “Draft Guidance”). The Draft Guidance...more

McGuireWoods LLP

Healthcare & Life Sciences Private Equity Deal Tracker: RoundTable Invests in Colorescience

McGuireWoods LLP on

RoundTable Healthcare Partners has announced it has invested in Colorescience. Colorescience, founded in 2013 and based in Carlsbad, California, is a skincare and sun protection brand....more

Wiley Rein LLP

FDA’s Draft Guidance for Cosmetics Industry Explains Records-Access Authority During Inspections

Wiley Rein LLP on

The U.S. Food and Drug Administration (FDA) has issued a draft guidance reminding the cosmetics industry that the agency can access a variety of business records during an inspection of a product’s responsible person and...more

ArentFox Schiff

FDA Issues Report on PFAS in Cosmetics: Key Findings, Risks, and Regulatory Implications

ArentFox Schiff on

Per- and polyfluoroalkyl substances (PFAS) are used as intentionally added ingredients in some cosmetic formulations, primarily on account of their water- and oil-resistance and long-lasting properties, for conditioning and...more

ArentFox Schiff

New Draft Guidance Addresses FDA’s Records Access Authority for Cosmetics Under MoCRA

ArentFox Schiff on

On January 21, the US Food and Drug Administration (FDA) issued a draft guidance clarifying the agency’s authority to access and copy records related to cosmetic products under the Modernization of Cosmetics Regulation Act of...more

Holland & Knight LLP

FDA Issues Report on PFAS in Cosmetics Products

Holland & Knight LLP on

In 2022, the Modernization of Cosmetics Regulations Act of 2022 (MoCRA) was signed into law, bringing about the largest expansion of the U.S. Food and Drug Administration's (FDA) authority to regulate cosmetics since passage...more

Holland & Knight LLP

Holland & Knight Health Dose: January 27, 2026

Holland & Knight LLP on

Passage of a multi-bill appropriations package now looks to potentially be in jeopardy, following events over the weekend in Minneapolis. U.S. Senate Minority Leader Chuck Schumer (D-N.Y.) issued a statement following a law...more

Goldberg Segalla

Beauty Isn’t Always Natural: FDA Releases Long-Awaited Report on PFAS in Cosmetic Products

Goldberg Segalla on

Recently, the Food and Drug Administration  (FDA) released its “Report on the Use of PFAS in Cosmetic Products and Associated Risks”, evaluating per- and polyfluoroalkyl substances (PFAS) and their use in cosmetic products....more

Loeb & Loeb LLP

"Talk Cleanly to Me"—Touting the Quality of Your Skincare and Beauty Products While Mitigating Class Action Litigation Risk

Loeb & Loeb LLP on

Assuming the title of this article prompted you to read on, it probably comes as no surprise to you that consumers' interest in the safety and quality of their skincare, fragrance and related personal care products is at an...more

Arnall Golden Gregory LLP

We’d Been Waiting Forever: FDA Issues Congressionally Mandated Report on Use of PFAS in Cosmetics

Key Takeaways - FDA delivered its first assessment of PFAS in cosmetics. Issued on December 29, 2025, the statutory deadline under MoCRA, the report is the first federal assessment of PFAS in cosmetic products and establishes...more

Haynes Boone

MoCRA Update: FDA’s Draft Q&A on Cosmetics Recall Authority

Haynes Boone on

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is considered the most significant expansion of the U.S. Food and Drug Administration’s (FDA) authority to regulate cosmetics since the enactment of the Food, Drug...more

MG+M The Law Firm

FDA PFAS Cosmetics Report Flags One Chemical for Potential Safety Concern

MG+M The Law Firm on

On December 29, 2025, the US Food and Drug Administration (FDA) published its Report on the Use of PFAS in Cosmetic Products and Associated Risks (Report). The Report, as required under the Modernization of Cosmetics...more

Harris Beach Murtha

FDA on PFAS in Cosmetic Products: Everything You Need to Know

Harris Beach Murtha on

The U.S. Food and Drug Administration recently released a report on its evaluation of PFAS in cosmetic products, concluding insufficient data to make a determination on safety....more

Venable LLP

FDA Issues MoCRA-Mandated PFAS Report on Cosmetics

Venable LLP on

FDA has released its report evaluating the safety of PFAS intentionally added to cosmetic products, as mandated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA)....more

Wiley Rein LLP

FDA Explains Its Mandatory Cosmetics Recall Authority, Adhering Closely to 2022 Statutory Language

Wiley Rein LLP on

The U.S. Food and Drug Administration (FDA, or the Agency) published a draft guidance explaining its mandatory recall authority for cosmetic products on December 18, 2025 (90 FR 59129). Entitled “Questions and Answers...more

ArentFox Schiff

FDA Proposes First New Sunscreen Active Ingredient in Two Decades

ArentFox Schiff on

For the first time in 26 years, the US Food and Drug Administration (FDA) has proposed adding a new active ingredient to the list of permissible sunscreen actives in the United States....more

Morgan Lewis

State PFAS Bans in Cosmetics Expand Ahead of 2026

Morgan Lewis on

The first wave of prohibitions on per- and polyfluoroalkyl substances (PFAS) in cosmetics and cosmetic products took effect earlier this year, with bans in California, Colorado, Maryland, Minnesota, and Washington commencing...more

Venable LLP

FDA's New Mandatory Cosmetics Recall Guidance: What You Need to Know

Venable LLP on

What does FDA's new guidance do? The enactment of the Modernization of Cosmetics Regulation Act (MoCRA) in 2022 provided FDA with the clear authority to mandate cosmetic recalls. Accordingly, FDA may order a recall when it...more

DLA Piper

Industrials Regulatory News and Trends - December 2025

DLA Piper on

Welcome to Industrials Regulatory News and Trends. In this regular bulletin, DLA Piper lawyers provide concise updates on key developments in the industrials sector to help you navigate the ever-changing business, legal, and...more

DLA Piper

Life Sciences News in Italy: November 2025

DLA Piper on

On 27 November 2025, Commission Decision (EU) 2025/2371 of 26 November 2025 declaring the functionality of the first four EUDAMED modules was published in the OJEU. ...more

ArentFox Schiff

FDA Withdraws Cosmetics Proposed Rule: Let Us (Not) Talk About Talc

ArentFox Schiff on

The US Food and Drug Administration (FDA) has withdrawn its proposed rule on standardized testing methods for detecting and identifying asbestos in talc-containing cosmetics, almost exactly one year after publication....more

Wiley Rein LLP

FDA Withdraws “Standardized” Asbestos Testing Proposal for Talc-Containing Cosmetics, With Intent to Reexamine and Reissue

Wiley Rein LLP on

On November 28, 2025, the U.S. Food and Drug Administration (FDA) withdrew its 2024 proposed rule entitled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products.” 90 FR 54603. The...more

Haynes Boone

MoCRA Update: FDA Withdraws Proposed Talc Rule, Citing MAHA Priorities and Testing Complexities

Haynes Boone on

On November 28, 2025, while most cosmetic companies were promoting their “Black Friday” deals for this year, the FDA quietly issued a Federal Register notice withdrawing the Agency’s previously proposed regulation for...more

Environmental General Counsel PC

The EU's Chemical Strategy is Reshaping Beauty and Fragrance Regulation

Regulatory pressures in the European Union are rapidly reshaping the landscape for cosmetics and fragrance companies. New hazard classes under the CLP Regulation, early national classification proposals, and forthcoming...more

Perkins Coie

FDA Withdraws Proposed Rule on Asbestos Testing Methods in Talc-Containing Cosmetic Products

Perkins Coie on

On November 28, 2025, the U.S. Food and Drug Administration (FDA) announced the withdrawal of its proposed rule entitled “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products—a notable...more

464 Results
 / 
View per page
Page: of 19

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide